IBDEI1HN ; ; 01-FEB-2022
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 01, 2022
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,24073,2)
 ;;=^5062827
 ;;^UTILITY(U,$J,358.3,24074,0)
 ;;=Z30.9^^82^1043^22
 ;;^UTILITY(U,$J,358.3,24074,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,24074,1,3,0)
 ;;=3^Contraceptive Management,Unspec
 ;;^UTILITY(U,$J,358.3,24074,1,4,0)
 ;;=4^Z30.9
 ;;^UTILITY(U,$J,358.3,24074,2)
 ;;=^5062828
 ;;^UTILITY(U,$J,358.3,24075,0)
 ;;=Z46.6^^82^1043^32
 ;;^UTILITY(U,$J,358.3,24075,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,24075,1,3,0)
 ;;=3^Fitting/Adjustment Urinary Device
 ;;^UTILITY(U,$J,358.3,24075,1,4,0)
 ;;=4^Z46.6
 ;;^UTILITY(U,$J,358.3,24075,2)
 ;;=^5063020
 ;;^UTILITY(U,$J,358.3,24076,0)
 ;;=Z71.7^^82^1043^26
 ;;^UTILITY(U,$J,358.3,24076,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,24076,1,3,0)
 ;;=3^Counseling,HIV
 ;;^UTILITY(U,$J,358.3,24076,1,4,0)
 ;;=4^Z71.7
 ;;^UTILITY(U,$J,358.3,24076,2)
 ;;=^5063251
 ;;^UTILITY(U,$J,358.3,24077,0)
 ;;=Z31.61^^82^1043^46
 ;;^UTILITY(U,$J,358.3,24077,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,24077,1,3,0)
 ;;=3^Procreat Cnsl/Advice,Nat Fam Plan
 ;;^UTILITY(U,$J,358.3,24077,1,4,0)
 ;;=4^Z31.61
 ;;^UTILITY(U,$J,358.3,24077,2)
 ;;=^5062839
 ;;^UTILITY(U,$J,358.3,24078,0)
 ;;=Z31.69^^82^1043^47
 ;;^UTILITY(U,$J,358.3,24078,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,24078,1,3,0)
 ;;=3^Procreat General Counseling/Advice
 ;;^UTILITY(U,$J,358.3,24078,1,4,0)
 ;;=4^Z31.69
 ;;^UTILITY(U,$J,358.3,24078,2)
 ;;=^5062841
 ;;^UTILITY(U,$J,358.3,24079,0)
 ;;=C49.4^^82^1043^41
 ;;^UTILITY(U,$J,358.3,24079,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,24079,1,3,0)
 ;;=3^Liposarcoma,Abdomen
 ;;^UTILITY(U,$J,358.3,24079,1,4,0)
 ;;=4^C49.4
 ;;^UTILITY(U,$J,358.3,24079,2)
 ;;=^5001132
 ;;^UTILITY(U,$J,358.3,24080,0)
 ;;=C79.51^^82^1043^16
 ;;^UTILITY(U,$J,358.3,24080,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,24080,1,3,0)
 ;;=3^Bone Mets
 ;;^UTILITY(U,$J,358.3,24080,1,4,0)
 ;;=4^C79.51
 ;;^UTILITY(U,$J,358.3,24080,2)
 ;;=^5001350
 ;;^UTILITY(U,$J,358.3,24081,0)
 ;;=C80.0^^82^1043^42
 ;;^UTILITY(U,$J,358.3,24081,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,24081,1,3,0)
 ;;=3^Neoplasm,Unknown Primary
 ;;^UTILITY(U,$J,358.3,24081,1,4,0)
 ;;=4^C80.0
 ;;^UTILITY(U,$J,358.3,24081,2)
 ;;=^5001388
 ;;^UTILITY(U,$J,358.3,24082,0)
 ;;=Z12.4^^82^1043^60
 ;;^UTILITY(U,$J,358.3,24082,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,24082,1,3,0)
 ;;=3^Screening,Cervical CA
 ;;^UTILITY(U,$J,358.3,24082,1,4,0)
 ;;=4^Z12.4
 ;;^UTILITY(U,$J,358.3,24082,2)
 ;;=^5062687
 ;;^UTILITY(U,$J,358.3,24083,0)
 ;;=Z12.73^^82^1043^63
 ;;^UTILITY(U,$J,358.3,24083,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,24083,1,3,0)
 ;;=3^Screening,Ovarian CA
 ;;^UTILITY(U,$J,358.3,24083,1,4,0)
 ;;=4^Z12.73
 ;;^UTILITY(U,$J,358.3,24083,2)
 ;;=^5062692
 ;;^UTILITY(U,$J,358.3,24084,0)
 ;;=D25.0^^82^1043^65
 ;;^UTILITY(U,$J,358.3,24084,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,24084,1,3,0)
 ;;=3^Submucous Leiomyoma,Uterus
 ;;^UTILITY(U,$J,358.3,24084,1,4,0)
 ;;=4^D25.0
 ;;^UTILITY(U,$J,358.3,24084,2)
 ;;=^267640
 ;;^UTILITY(U,$J,358.3,24085,0)
 ;;=D25.1^^82^1043^40
 ;;^UTILITY(U,$J,358.3,24085,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,24085,1,3,0)
 ;;=3^Intramural Leiomyoma,Uterus
 ;;^UTILITY(U,$J,358.3,24085,1,4,0)
 ;;=4^D25.1
 ;;^UTILITY(U,$J,358.3,24085,2)
 ;;=^267641
 ;;^UTILITY(U,$J,358.3,24086,0)
 ;;=D25.2^^82^1043^66
 ;;^UTILITY(U,$J,358.3,24086,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,24086,1,3,0)
 ;;=3^Subserosal leiomyoma,Uterus
